Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
InnoCan Pharma Logo
InnoCan Pharma Growth Score
40
CB Rank
115116
Heat Score
43
InnoCan Pharma is a pharma tech company.that develops novel therapeutics platforms and products to improve quality of life.
Founded
obfuscation
PublicPost-IPO Debt Herzliya, Tel Aviv, Israel1-10 innocanpharma.com/
Biotechnology
Health Care
Medical
Pharmaceutical
Therapeutics
Overview

InnoCan Pharma
Total Funding
obfuscation
Growth Score
40
Heat Score
43

Total Funding
obfuscation
obfuscation
Post-IPO Debt raised
obfuscation
Growth Score40
-7 pts
in past quarter
Heat Score 43
-16 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About InnoCan Pharma

CB Rank
115116
InnoCan Pharma is a pharma tech company.that develops novel therapeutics platforms and products to improve quality of life.
Founded
obfuscation
PublicPost-IPO Debt Herzliya, Tel Aviv, Israel1-10 innocanpharma.com/
Biotechnology
Health Care
Medical
Pharmaceutical
Therapeutics

Funding Rounds

Post-IPO Debt
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Debt
OBF
in
obfuscation

Key People

Details

Legal Name InnoCan Pharma Corp.
Operating Status Active
Stock Symbol  CNSX:INNO
Company Type For Profit
Founders  Yoram Drucker
About the Company

Cannabinoids interact with the endocannabinoid receptor system, which is located throughout the body and plays an important role in many processes. InnoCan aims to harness the power of cannabinoids to target a wide variety of health problems. InnoCan plans to initially innovate new dermatology treatments, where research shows topical

cannabinoid-combined treatments are highly effective.

Phone Number +972.54.471.1171
Contact Email info@innocanpharma.com
Predictions & Insights

Growth Insight

See this Growth Insight
InnoCan Pharma is
Lorem
 to be growing
Top Contributing Factors
Financial Decline

Products & Services

CBD-Infused Sleeping Mask
A topical skincare product containing cannabidiol (CBD) designed to reduce signs of aging such as wrinkles and fine lines by delivering CBD to deeper skin layers.
CBD Roll-On
A topical analgesic product containing cannabidiol (CBD) combined with menthol, magnesium, and camphor to relieve pain, inflammation, and muscle soreness.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 11
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - InnoCan Pharma Logo
Post-IPO Debt - InnoCan Pharma
1
obfuscation
Tamar InnovestPost-IPO Debt
obfuscation
Post-IPO Debt - InnoCan Pharma Logo
Post-IPO Debt - InnoCan Pharma
1
obfuscation
Tamar InnovestPost-IPO Debt
obfuscation
Post-IPO Debt - InnoCan Pharma Logo
Post-IPO Debt - InnoCan Pharma
1
obfuscation
Tamar InnovestPost-IPO Debt
obfuscation
Post-IPO Debt - InnoCan Pharma Logo
Post-IPO Debt - InnoCan Pharma
1
obfuscation
Tamar InnovestPost-IPO Debt
obfuscation
Post-IPO Debt - InnoCan Pharma Logo
Post-IPO Debt - InnoCan Pharma
1
obfuscation
Tamar InnovestPost-IPO Debt

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 11
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - InnoCan Pharma Logo
Post-IPO Debt - InnoCan Pharma
1
obfuscation
Tamar InnovestPost-IPO Debt
obfuscation
Post-IPO Debt - InnoCan Pharma Logo
Post-IPO Debt - InnoCan Pharma
1
obfuscation
Tamar InnovestPost-IPO Debt
obfuscation
Post-IPO Debt - InnoCan Pharma Logo
Post-IPO Debt - InnoCan Pharma
1
obfuscation
Tamar InnovestPost-IPO Debt
obfuscation
Post-IPO Debt - InnoCan Pharma Logo
Post-IPO Debt - InnoCan Pharma
1
obfuscation
Tamar InnovestPost-IPO Debt
obfuscation
Post-IPO Debt - InnoCan Pharma Logo
Post-IPO Debt - InnoCan Pharma
1
obfuscation
Tamar InnovestPost-IPO Debt

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Tamar Innovest Logo
Tamar Innovest
Yes
Post-IPO Debt - InnoCan Pharma Logo
Post-IPO Debt - InnoCan Pharma
—
Tamar Innovest Logo
Tamar Innovest
Yes
Post-IPO Debt - InnoCan Pharma Logo
Post-IPO Debt - InnoCan Pharma
—
Tamar Innovest Logo
Tamar Innovest
Yes
Post-IPO Debt - InnoCan Pharma Logo
Post-IPO Debt - InnoCan Pharma
—
Tamar Innovest Logo
Tamar Innovest
Yes
Post-IPO Debt - InnoCan Pharma Logo
Post-IPO Debt - InnoCan Pharma
—
Tamar Innovest Logo
Tamar Innovest
Yes
Post-IPO Debt - InnoCan Pharma Logo
Post-IPO Debt - InnoCan Pharma
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3 Contacts 2

Employee Profiles

News

News and Press

News•May 27, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 27, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 27, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 6, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

727
-91.71%
 in past month

IT Spend

$2.3MThis year, InnoCan Pharma is projected to spend $2.3M on IT, according to Aberdeen.

Active Website Tech Count

39InnoCan Pharma is actively using 39 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  SSL by Default.

Total IP

17The intellectual property of InnoCan Pharma includes 9 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, InnoCan Pharma has registered 8 trademarks with the most popular class being 'Bleaching, cleaning, polishing, scouring and abrasive preparations; cosmetics', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is InnoCan Pharma's headquarters? InnoCan Pharma is located in Herzliya, Tel Aviv, Israel.Who invested in InnoCan Pharma? InnoCan Pharma has 2 investors including Tamar Innovest and  Tamar Innovest.When was the last funding round for InnoCan Pharma? InnoCan Pharma closed its last funding round on
obfuscation
from a Post-IPO Debt round.Who are InnoCan Pharma's competitors? Alternatives and possible competitors to InnoCan Pharma may include CBDaCasa, CBD Alchemy, and  Hemplife.How much funding has InnoCan Pharma raised to date? InnoCan Pharma has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8b214dc 1)
|